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Introduction {#sec1}
============

Pluripotency emerges in the mammalian epiblast during preimplantation blastocyst development. At the eight-cell stage, the embryo undergoes compaction and outer cells are directed toward the trophectoderm lineage. Interior cells become the inner cell mass (ICM) and subsequently diverge into pluripotent epiblast and extraembryonic primitive endoderm (PrE). In rodents, the preimplantation epiblast state can be captured in vitro as embryonic stem cells (ESCs) ([@bib17], [@bib48]) and sustained indefinitely using defined media ([@bib13], [@bib41], [@bib96]). The unrestricted potential of ESCs to generate all somatic tissues and the germline is termed "naive" pluripotency, and differs from other in vitro pluripotent states with respect to gene expression, signaling requirements, and epigenetic status ([@bib11], [@bib40], [@bib45], [@bib53], [@bib80]).

Individual epiblast cells rapidly lose the ability to give rise to self-renewing ESC colonies upon implantation ([@bib8]), evidencing the transient nature of naive identity in normal development. The transition from the naive state is poorly characterized in vivo and in vitro. Upon implantation, epiblast cells acquire epithelial polarity ([@bib5]) and lose naive pluripotency marker expression entirely by embryonic day (E)5.5 ([@bib8]). However, the transcriptional network associated with this progression has been ill defined.

Pluripotency can be suspended in utero during diapause, a facultative condition of embryonic arrest ([@bib44], [@bib50], [@bib63]). Embryonic diapause by delayed implantation has evolved to overcome conditions unfavorable for reproduction ([@bib30], [@bib44], [@bib50]) and occurs in over 100 mammalian species ([@bib63]). The distinction between transient, diapaused, and self-renewing pluripotent states remains elusive ([@bib54]).

Human and nonhuman primate pluripotent cells are maintained in vitro with culture regimes distinct from those used for mouse ESCs. They exhibit marked differences in gene expression compared to primate preimplantation embryos ([@bib51], [@bib83], [@bib84], [@bib92]). Propagation of nonhuman primate ESCs competent for chimera contribution has proven elusive ([@bib32], [@bib73]), although recent progress was reported for rhesus macaque using altered culture conditions ([@bib19]). It is unclear why primate embryonic cells are more refractory to authentic ESC derivation compared to mouse. One contributing factor could be differences in signaling pathways driving lineage commitment and segregation in the ICM, which have not been defined in the primate.

Advances in sequencing protocols have enabled quantitative analysis of picogram amounts of RNA from individual cells and facilitated the study of early mammalian development at unprecedented resolution ([@bib23], [@bib35], [@bib76]). However, sequencing from minute quantities of starting material compromises the detection of low-abundance transcripts and impairs accurate estimation of expression levels ([@bib10], [@bib22]). These limitations reduce the potential for comprehensive molecular characterization of individual cells. Here we show that this can be mitigated by applying single-cell sample preparation methods to small groups of cells. We adapted single-cell reverse-transcription and preamplification ([@bib76]) for compatibility with Illumina sequencing and profiled clusters of 8--20 cells. This approach yields substantial enhancement in transcript detection and is suitable for experiments that call for accurate analysis of small cell numbers without a requirement to measure cell-to-cell variability.

We apply this technique to produce a transcriptional map of early mouse development from morula to postimplantation epiblast, and compare in vitro cultured ESCs and diapaused epiblasts in the context of this developmental sequence. We extend this analysis to the common marmoset (*Callithrix jacchus*), a small New World monkey presenting several practical advantages as a model for primate embryology. Profiling transcriptional activity in the inner cell mass of early-, mid-, and late-stage marmoset blastocysts allows direct comparison of rodent and primate development. These data reveal differences in regulatory timing and utilization of signaling pathways that we investigate through embryo culture experiments. Our results provide a framework for delineating the emergence and developmental progression of pluripotency in diverse mammals.

Results {#sec2}
=======

A Transcriptional Map of Early Mouse Development {#sec2.1}
------------------------------------------------

We previously showed by qRT-PCR that a moderate increase in starting material for whole-transcriptome amplification ([@bib76]) substantially increases signal fidelity and reproducibility ([@bib8]). We extend this approach to RNA sequencing (RNA-seq) to profile cell lineages from individual mouse embryos. Four time points were analyzed from the eight-cell stage at E2.5 to the early postimplantation epiblast at E5.5 ([Figure 1](#fig1){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}). *Pdgfra::GFP* knockin mice ([@bib25], [@bib61]) enabled fluorescence-based separation of PrE from epiblast cells in E4.5 and E5.5 blastocysts.

We assessed transcript detection and expression-level estimation relative to previously published single-cell ([@bib90], [@bib92]) and conventional RNA-seq data ([@bib14], [@bib45]). Transcription was measured from up to 30% of annotated genes by single-cell RNA-seq, consistent with previous reports ([@bib10], [@bib22]). RNA-seq from 10--20 cells (8 in the case of E2.5 morulae) yielded detection rates of 60%--70%, comparable to the performance of sequencing protocols from microgram quantities of RNA ([Figure 1](#fig1){ref-type="fig"}B). Similar distribution profiles were observed from bulk RNA and small numbers of cells, with many genes expressed at low and intermediate levels and a small proportion showing high expression ([Figure 1](#fig1){ref-type="fig"}C). In contrast, single-cell data exhibit high expression-level estimates for many genes and missing values for low-abundance transcripts ([@bib31]). These results demonstrate that profiling small cell clusters overcomes limitations in sensitivity of single-cell analysis and allows quantification of gene expression levels comparable to that of conventional transcriptome sequencing.

Analysis of biological replicates spanning the five embryonic stages produced discrete clusters, recapitulating their developmental sequence ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Visualization by diffusion map, a nonlinear dimensionality reduction method ([@bib37]), shows that samples cluster primarily by stage, with the first coefficient capturing progression of development ([Figure 1](#fig1){ref-type="fig"}D). PrE and preimplantation epiblast cells retain a high degree of similarity despite the divergent developmental potential of the two lineages ([Figure 1](#fig1){ref-type="fig"}D; [Figure S1](#mmc1){ref-type="supplementary-material"}A).

We examined pluripotency and lineage markers in more detail. Our data confirm the sequential activation of PrE specifiers previously described ([Figure S1](#mmc1){ref-type="supplementary-material"}B) ([@bib4], [@bib15], [@bib21], [@bib23], [@bib35], [@bib58]), whereas preimplantation epiblast cells exhibited robust expression of exclusive markers including *Sox2*, *Nanog*, *Klf2*, *Bmp4*, and *Fgf4* ([@bib23], [@bib35], [@bib77]). Strikingly, however, several transcription factors associated with pluripotency were expressed in both lineages. *Pou5f1* (*Oct4*) was expressed at lower levels but was still present in PrE, consistent with known protein distribution ([@bib20], [@bib38], [@bib59]). This pattern was evident for *Klf4*, *Dppa3*, *Nr0b1*, *Esrrb*, and *Zfp42* (*Rex1*). *Klf5* and *Tbx3* were expressed at higher levels in PrE ([Figure 1](#fig1){ref-type="fig"}E). This observation is reflected in the cluster proximity of PrE and the preimplantation epiblast ([Figure 1](#fig1){ref-type="fig"}D). These results illustrate that divergent potency of related embryonic lineages can be conferred by a small subset of regulatory factors in the context of a globally similar transcriptome.

Defining Stage-Specific Gene Expression Modules in Early Mouse Development {#sec2.2}
--------------------------------------------------------------------------

Lineage-specific profiling facilitated identification of gene sets indicative of developmental state, lineage segregation, and progression. We defined dynamically expressed genes as those transcribed differentially between at least two of the four embryonic stages analyzed and robustly detected in at least one (fragments per kilobase of exon per million fragments mapped \[FPKM\] [\>]{.ul} 10). The resultant set comprises 1,857 genes ([Table S2](#mmc3){ref-type="supplementary-material"}), and hierarchical clustering revealed ten expression modules ([Figure 2](#fig2){ref-type="fig"}A; [Figure S2](#mmc1){ref-type="supplementary-material"}A).

Genes maximally expressed in morulae included *Tead4*, *Sox15*, *Klf17*, *Nr5a2*, and *Tfap2c*. Those common to morulae and the ICM were *Gata6*, as well as trophectodermal markers *Hand1*, *Elf3*, and *Eomes*. The latter group may underlie the capacity of early ICM cells to regenerate trophectoderm ([@bib27], [@bib52], [@bib65]). Genes expressed throughout preimplantation development but at varying levels included ESC markers *Klf2*, *Klf4*, *Klf5*, *Nr0b1*, *Zfp42*, *Prdm14*, *Tbx3*, *Tfcp2l1*, and *Esrrb*. These data provide a comprehensive set of transcription factors and other genes downregulated upon implantation ([Table S2](#mmc3){ref-type="supplementary-material"}).

In addition to *Pou5f1* (*Oct4*) and *Sall4*, pluripotency markers associated with both pre- and postimplantation epiblast include *Utf1*, *Foxd3*, *Zic3*, and *Fgf4*. *Tcf7l1* (*Tcf3*), a gene expressed in embryonic stem cells and involved in pluripotency repression ([@bib46], [@bib88], [@bib95]), was upregulated at E4.5, potentially to prepare naive epiblast cells for transition. Notably, 220 genes were specifically upregulated during the preimplantation-to-postimplantation epiblast transition. These include known regulators of early postimplantation development, such as *Pou3f1* (*Oct6*), *Fgf5*, *Otx2*, and *Sox3*, as well as candidate regulators *Tead2*, *Sall2*, *Mapk12*, *Fzd2*, *Rspo1*, *Smo*, and *Notch3*. We also observed strong upregulation of de novo methyltransferases *Dnmt3a* and *Dnmt3b*, consistent with hypomethylation in naive pluripotent cells ([@bib40], [@bib69]) and increased DNA methylation upon implantation ([@bib39]).

Genes expressed at high levels throughout the developmental stages analyzed are listed in [Table S3](#mmc4){ref-type="supplementary-material"}, and expression modules specific to the epiblast versus PrE segregation process are provided in [Figure S2](#mmc1){ref-type="supplementary-material"}B and [Table S4](#mmc5){ref-type="supplementary-material"}. These results expand the recent description of PrE-associated genes by single-cell microarray profiling ([@bib58]) and provide a resource to identify regulators of PrE differentiation.

The initial progression from naive pluripotency in embryonic development has not been well characterized. We analyzed the E4.5-to-E5.5 transition before epiblast cells undergo lineage priming in vivo and provide the complete set of differentially expressed genes in [Table S5](#mmc6){ref-type="supplementary-material"}. To examine the behavior of an independent set of pluripotency-associated genes, we used PluriNetWork, curated from published interaction data ([@bib72]). Focusing on dynamically expressed genes and the core regulators *Pou5f1*, *Nanog*, and *Sox2*, we reduced the network to 82 nodes (PluriNet82; [Figure 2](#fig2){ref-type="fig"}B). Importantly, the condensed network includes all validated regulators of ESC pluripotency. Those downregulated during the E4.5-to-E5.5 transition include naive markers Esrrb, Nr0b1, Klf2, Klf4, Klf5 and Zfp42 (Rex1), as well as Lifr, Il6st (gp130), Spp1, Tcl1, and Zfp57. Conversely, we observed upregulation of *Foxd3*, *Lef1*, *Ccnd1*, *Zscan10*, *Phc1*, and *Nr216* upon implantation.

Visualization of temporal patterns shows robust expression of naive markers during preimplantation development followed by an abrupt shutdown and replacement with factors such as *Nodal*, *Lef1*, and *Fgf5*, along with the activin receptor *Acvr2b* ([Figure 2](#fig2){ref-type="fig"}C). Epigenetic modifiers associated with a permissive chromatin state (*Tet1*, *Tet2*, *Prdm14*, *Ncoa3*) were predominant during preimplantation development ([Figure 2](#fig2){ref-type="fig"}D). Upon implantation, these were exchanged for epigenetic regulators mediating DNA methylation (*Dnmt1*, *Dnmt3a*, *Dnm3b*) and transition to more closed chromatin configurations (*Hdac5*, *Hdac11*, *Suv39h1*).

We integrated the RNA-seq data with 229 annotated Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and generated expression maps for pairwise comparison of developmental stages (<http://pathway-atlas.stemcells.cam.ac.uk>). At the preimplantation-to-postimplantation epiblast transition, we noted differential expression of genes involved in tight junction formation ([Figure 1](#fig1){ref-type="fig"}E). In particular, we detected upregulation of *Cldn6*, important for epithelial formation ([@bib85]) and upregulated in mouse epiblast-derived stem cells ([@bib80]), and *Cldn7* with *Tjp1*, essential for tight junction establishment ([@bib49], [@bib68]). We also noted induction of *Crb3* and *Pard3*, pivotal for the establishment and maintenance of apical-basal polarity ([@bib67]). These results comprise a reference dataset for regulatory network and pathway analysis during epiblast progression in vivo.

The Transcriptional Circuitry for ESC Identity Is Assembled in the Preimplantation Epiblast {#sec2.3}
-------------------------------------------------------------------------------------------

We sequenced RNA from ESCs cultured in 2i/LIF (leukemia inhibitory factor) without feeders or serum ([@bib96]), processed identically to embryonic samples to allow direct comparison. Global analysis showed tight correlation between biological replicates and confirmed the shared identity of ESCs and the preimplantation epiblast ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Restricting the comparison to dynamically expressed genes reveals concordance in the developmental state, with ESCs displaying a near-identical profile to the E4.5 epiblast ([Figure 3](#fig3){ref-type="fig"}A; [Figure S3](#mmc1){ref-type="supplementary-material"}C). Consistent with this, genes differentially expressed between ESCs and embryonic cells were fewest for the E4.5 epiblast, indicating the greatest correspondence with emergent pluripotent cells in the blastocyst ([Figure 3](#fig3){ref-type="fig"}B). Pathway enrichment analyses showed most changes in ESCs to be associated with metabolism, potentially rooted in the biophysical environment and nutrient utilization ([Figure 3](#fig3){ref-type="fig"}C).

We examined the behavior of regulatory networks governing pluripotency in ESCs in the context of in vivo development. To capture changes over time, we computed normalized expression relative to the mean level of each gene across all developmental stages and defined genes with positive values as preferentially active at a given stage. Mapping these values to PluriNet82 reveals changes in network topology during early mouse development ([Figure 3](#fig3){ref-type="fig"}D). Few pluripotency genes exhibited robust expression at the morula stage, with substantially more upregulated in the early ICM. Most peaked at the preimplantation epiblast stage, resulting in maximum interconnectivity. This was abolished following implantation, marking the dissolution of naive pluripotency in vivo.

We proposed a reduced set of abstract Boolean network models for ESC self-renewal comprising 11 transcription factors and the extracellular signal-regulated kinase (Erk)/mitogen-activated protein (MAP) kinase ([@bib16]). To relate this to the embryo, we asked whether a developmental stage can be identified at which all components are present. Intersecting data from morula, early ICM, and pre- and postimplantation epiblast cells revealed that the only time point at which these regulators were coexpressed was the preimplantation epiblast ([Figure 3](#fig3){ref-type="fig"}E). Thus, transcriptional regulation in cultured ESCs correlates specifically with the naive phase of pluripotency in the embryo.

Diapaused Epiblasts Maintain All Features of Naive Pluripotency {#sec2.4}
---------------------------------------------------------------

Rodents have evolved the capacity for facultative developmental arrest at the late blastocyst stage ([@bib44], [@bib50], [@bib63]). ESCs were first obtained from embryos in diapause ([@bib17]), and the condition is known to facilitate ESC derivation ([@bib12]). We induced implantation delay by ovariectomy ([@bib87]) and isolated diapaused epiblasts for RNA-seq as above. Diapaused embryos vary from those undergoing normal development ([Figure 4](#fig4){ref-type="fig"}A) and cluster separately by correlation analysis ([Figure S4](#mmc1){ref-type="supplementary-material"}A). To characterize these differences, we examined Gene Ontology (GO) term enrichment for differentially expressed genes ([Figure S4](#mmc1){ref-type="supplementary-material"}B). In diapause, the most significant downregulated processes relate to metabolism, cell cycle, and biosynthesis. Conversely, those upregulated include negative regulation of metabolism and biosynthetic processes. Apart from peroxisome proliferator-activated receptor (PPAR) signaling, pathway expression scores were generally reduced in diapaused epiblasts and particularly components of the mechanistic target of rapamycin (mTOR) pathway ([Figure 4](#fig4){ref-type="fig"}B). These features likely reflect a general state of dormancy in diapaused embryos.

We found all pluripotency factors to be expressed in the diapaused epiblast, indicating retention of naive identity ([Figure S4](#mmc1){ref-type="supplementary-material"}C). It has been shown that *Lifr* and *Il6st* serve an essential function in epiblast maintenance during diapause ([@bib56]), implicating the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in sustaining pluripotency. Analysis of JAK/STAT components revealed that receptors, signal transducers, and downstream targets are robustly expressed in normal preimplantation development, ESCs, and diapaused epiblasts but are not maintained postimplantation ([Figure 4](#fig4){ref-type="fig"}C). Pluripotency factor targets of Stat3, Klf4, and Tfcp2l1 ([@bib9], [@bib24], [@bib47], [@bib97], [@bib93]) were expressed at high levels in diapause. We also observed substantial upregulation of *Wnt4*, concomitant with high expression of the WNT targets *Esrrb* ([@bib46]), *Axin2* ([@bib43]), and *Cdx1* ([@bib60]) ([Figure 4](#fig4){ref-type="fig"}C; [Figure S4](#mmc1){ref-type="supplementary-material"}C). *Wnt* expression in normal development was mainly confined to the early ICM (*Wnt6*, *Wnt7b*), with low levels of *Wnt4* present in all stages analyzed. Thus, WNT signaling may play a specific role in extended maintenance of the pluripotency network during diapause.

We assessed genome-wide differences in expression of transcription factors and epigenetic regulators between the preimplantation epiblast, diapause, and ESC ([Figure 4](#fig4){ref-type="fig"}D). Few factors were highly expressed in only one condition and most were present in at least two, in particular ESC and preimplantation epiblast or ESC and diapause. Expression modules including all genes for preimplantation epiblast, diapause, and ESC appear in [Table S4](#mmc5){ref-type="supplementary-material"}. ESC-specific transcripts include *Phgdh* and *Aldoa*, involved in glycolysis and L-serine biosynthesis, respectively ([Figure 4](#fig4){ref-type="fig"}E). *Piwil4*, a repressor of transposable elements, and *Sod3*, a superoxide dismutase, may act to maintain genomic integrity during diapause. Genes highly upregulated in both diapause and ESC included *Socs3*, a JAK/STAT downstream target, and *Stard4*, encoding a putative lipid transfer protein. We examined the relationship of diapaused epiblasts to embryo samples and ESCs based on all 1,857 genes dynamically expressed during normal development. Remarkably, diapause samples were placed directly adjacent to the preimplantation epiblast and ESC in the diffusion map ([Figure 4](#fig4){ref-type="fig"}F). These results show self-renewing ESCs and diapaused embryos to embody an arrested state of the transient E4.5 epiblast that retains developmental identity, despite substantial changes in environment in the case of ESCs and profound changes in metabolism, proliferation, and biosynthetic activity in diapause.

Direct Comparison of Rodent and Primate ICM {#sec2.5}
-------------------------------------------

Preimplantation embryogenesis in primates is protracted relative to rodents, and detailed molecular and functional characterizations are lacking. Protocols for minimally invasive embryo recovery have been developed for marmoset, providing access to embryos that have undergone normal gestation in utero ([@bib82], [@bib26]), a resource that is not accessible from humans. We therefore utilized the common marmoset to investigate the transcriptional makeup of primate ICM in comparison to early mouse development.

Marmoset embryos were collected by nonsurgical uterine flush. The ICMs of early-, mid-, and late-stage blastocysts were isolated by immunosurgery ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C) and profiled by RNA-seq ([Table S6](#mmc7){ref-type="supplementary-material"}). Marmoset ICMs were processed whole due to lack of reporter systems in the primate. Mixed expression of epiblast and PrE markers is therefore expected from late ICM ([Figures 5](#fig5){ref-type="fig"}C and 5D). Samples clustered largely by developmental stage ([Figure S5](#mmc1){ref-type="supplementary-material"}H). Substantial differences between species were apparent ([Figure 5](#fig5){ref-type="fig"}B), embodied primarily in the first diffusion coefficient. The second coefficient appears to reflect progression of development in both mammals.

Expression of many pluripotency factors, including *Pou5f1*, *Sox2*, *Nanog*, *Esrrb*, *Klf4*, *Tbx3*, and *Tdgf1*, was conserved between species ([Figure 5](#fig5){ref-type="fig"}C). However, we noted changes in PluriNet82 connectivity imparted by the absence of *KLF2*, *FBXO15*, *NR0B1*, and *GBX2* in marmoset ([Figure 2](#fig2){ref-type="fig"}B). Two of these, *Klf2* and *Gbx2*, are proposed core naive pluripotency regulators in mouse ESCs ([Figure 3](#fig3){ref-type="fig"}E). We then assessed localization of naive pluripotency factors by immunofluorescence at the early-mid blastocyst stage. KLF4 and TFCP2L1 were predominantly expressed in the ICM and largely correlated with NANOG, albeit with slightly broader distribution ([Figures 5](#fig5){ref-type="fig"}D and 5E). These factors are thus coexpressed in a subset of ICM cells in the marmoset blastocyst, as also observed in human ([@bib75]). Intriguingly, E-CADHERIN staining was intense in the trophectoderm but diffuse in the ICM ([Figure 5](#fig5){ref-type="fig"}E).

Distinctions evident from the wider pluripotency network prompted us to investigate potential differences in epiblast and PrE specification in primate ICM. In mouse, sequential activation of early PrE markers (*Gata6*, *Pdgfra*) is followed by upregulation of late markers (*Gata4*, *Foxa2*) upon lineage segregation ([Figure 5](#fig5){ref-type="fig"}F). The majority of key PrE regulators, including *GATA6*, *SOX17*, and *GATA4*, were also present at high abundance in marmoset ICM. We performed further immunostaining for *GATA4* and *GATA6* to assess specificity to PrE. Initially, NANOG and GATA6 were coexpressed in the early ICM ([Figure 5](#fig5){ref-type="fig"}G), similar to mouse ([@bib61], [@bib66]) and human ([@bib64]). At the mid-blastocyst stage, we observed mutually exclusive staining of NANOG and SOX17 ([Figure 5](#fig5){ref-type="fig"}H). KLF4 was expressed at low levels throughout the embryo, but with stronger signal in NANOG-positive cells of the ICM ([Figure 5](#fig5){ref-type="fig"}H). OCT4 tightly colocalized with NANOG in the presumptive epiblast of late blastocysts ([Figure 5](#fig5){ref-type="fig"}I). In contrast, GATA4 and OCT4 staining were mutually exclusive in the ICM, with GATA4 specific to PrE and OCT4 confined to the epiblast ([Figure 5](#fig5){ref-type="fig"}J). Confocal microscopy of late marmoset blastocysts revealed that GATA6-positive cells formed a distinct layer overlying NANOG-positive cells within the ICM, indicating restriction of GATA6 to PrE ([Figure 5](#fig5){ref-type="fig"}K). We conclude that mouse and marmoset share the majority of PrE specifiers.

FGF and WNT Signaling Are Required for Lineage Segregation in the Marmoset Blastocyst {#sec2.6}
-------------------------------------------------------------------------------------

To further relate mouse and marmoset embryos, we combined data from E4.5 epiblast and PrE mouse samples to allow comparison to the late marmoset ICM ([Figure S5](#mmc1){ref-type="supplementary-material"}J; [Table S7](#mmc8){ref-type="supplementary-material"}). Hierarchical clustering of an independent panel of genes selected by the International Stem Cell Initiative ([@bib1]) revealed broad conservation in expression patterns of many pluripotency and lineage markers but differences in signaling pathway components, including *Lifr*, *Fgf4*, and *Nodal* ([Figure S5](#mmc1){ref-type="supplementary-material"}J). Knowledge of pathways regulating PrE segregation and epiblast specification in primates is limited. We focused on the regulation of pathway components at the early ICM stage, when *NANOG* and *GATA6* are coexpressed ([Figure 5](#fig5){ref-type="fig"}G) and individual cells are indistinguishable at the transcriptome level in mouse ([@bib58]). The most significant differentially expressed pathways in marmoset included ascorbate and aldorate, inositol phosphate and lipoic acid metabolism, lysine biosynthesis, and PPAR signaling ([Figure S5](#mmc1){ref-type="supplementary-material"}I). Pathways upregulated in mouse included arginine and proline metabolism and proteasome, estrogen receptor, and mTOR signaling. These results highlight metabolic differences, in particular with regard to amino acid biosynthesis, between the mouse and marmoset embryo.

We then examined signaling pathways by combining gene expression with KEGG pathway maps. We observed pronounced differences in major cascades such as transforming growth factor β (TGF-β), fibroblast growth factor (FGF), and WNT ([Figures 6](#fig6){ref-type="fig"}A--6C; [Figure S6](#mmc1){ref-type="supplementary-material"}). Marmoset early ICM cells expressed high levels of *ACVR1B* (*ALK4*), *TGFBR1* (*ALK5*), and *ACVR2A* ([Figure 6](#fig6){ref-type="fig"}A; [Figure S6](#mmc1){ref-type="supplementary-material"}A). Interestingly, *BMP4* is not detected in marmoset ([Figure S6](#mmc1){ref-type="supplementary-material"}D), but *NODAL* is expressed from the early blastocyst stage ([Figure 6](#fig6){ref-type="fig"}A; [Figure S6](#mmc1){ref-type="supplementary-material"}A). *FGF4* is absent in the early ICM and is upregulated at later stages. Additionally, we noted altered levels of FGF receptor expression ([Figure 6](#fig6){ref-type="fig"}C; [Figure S6](#mmc1){ref-type="supplementary-material"}C). In relation to WNT signaling, the secreted Wnt inhibitor *DKK1* and the negative regulator of β-catenin *GSK3β* were highly upregulated, which together with reduced β-catenin (*CTNNB1*) ([Figure 6](#fig6){ref-type="fig"}B; [Figure S6](#mmc1){ref-type="supplementary-material"}B) may indicate suppression of WNT signaling in the early primate ICM. At the late blastocyst stage, however, *DKK1* diminished, concomitant with an increase in *CDX1*. This suggests the possibility of a specific role for the WNT pathway in the marmoset blastocyst. Thus, although transcription factor expression is largely conserved between the rodent and primate embryo stages examined, the repertoire of signaling pathway components differs.

To investigate the functional relevance of these expression patterns, marmoset morulae were cultured to the late blastocyst stage in the presence of selective pathway inhibitors ([Figure 6](#fig6){ref-type="fig"}D). Embryos were subsequently immunostained for NANOG, GATA6, and CDX2. Cell number and fluorescence intensities were measured with automated analysis software (Volocity; PerkinElmer) ([Figure 6](#fig6){ref-type="fig"}E, left column; [Figures S7](#mmc1){ref-type="supplementary-material"}A--S7F). Mouse embryos were cultured and analyzed under identical conditions for direct comparison. Inhibitor treatment did not affect total cell number ([Figure S7](#mmc1){ref-type="supplementary-material"}G). In marmoset DMSO-treated controls, the epiblast and PrE had segregated in late blastocysts, as indicated by mutually exclusive NANOG (NANOG-only) and GATA6 (GATA6-only) staining in subsets of inner cells ([Figure 6](#fig6){ref-type="fig"}D, arrowheads). GATA6 was also expressed in the trophectoderm, but at lower levels and in combination with CDX2 ([Figures S7](#mmc1){ref-type="supplementary-material"}G and S7H). The ratio of epiblast (NANOG-only) to PrE (GATA6-only) cells was higher in marmoset embryos compared to mouse ([Figure 6](#fig6){ref-type="fig"}E).

In mouse embryos, inhibition of FGF signaling ablated PrE formation and increased the epiblast compartment ([Figure 6](#fig6){ref-type="fig"}E), whereas inhibition of WNT and TGF-β/Nodal signaling did not elicit significant effects, consistent with previous reports ([@bib6], [@bib57], [@bib91]). In marmoset, blocking the type I TGF-β/activin/Nodal receptor with A8301 did not disrupt lineage segregation (arrowheads for GATA6-only cells in [Figure 6](#fig6){ref-type="fig"}D). However, inhibition of ERK or WNT signaling led to coexpression patterns rarely observed in control embryos ([Figure 6](#fig6){ref-type="fig"}E; [Figure S7](#mmc1){ref-type="supplementary-material"}H). NANOG-only cells in marmoset embryos increased upon ERK pathway inhibition ([Figures 6](#fig6){ref-type="fig"}D--6F). WNT signaling inhibition led to strong upregulation of NANOG, GATA6, and CDX2, and in particular the number of NANOG-high cells was substantially greater ([Figures 6](#fig6){ref-type="fig"}D, 6E, and 6G). Strikingly, emergence of GATA6-only PrE cells was suppressed by both ERK and WNT signaling inhibition ([Figure 6](#fig6){ref-type="fig"}H; [Figure S7](#mmc1){ref-type="supplementary-material"}I).

We assessed whether the observed effects of TGF-β, WNT, and ERK inhibition might be combined by carrying out dual-inhibition experiments ([Figure 7](#fig7){ref-type="fig"}A). Conditions including WNT inhibition led to greater proportions of NANOG-only cells ([Figure 7](#fig7){ref-type="fig"}B), with a substantial increase in NANOG-high cells ([Figure 7](#fig7){ref-type="fig"}C). PrE formation was impaired in all dual-inhibition experiments ([Figures 7](#fig7){ref-type="fig"}A and 7D). The most profound reduction occurred when both WNT and ERK signaling were inhibited ([Figure 7](#fig7){ref-type="fig"}D), indicating an additive effect. These results support a conserved role for FGF/ERK signaling and a marmoset-specific function for WNT signaling in ICM lineage segregation ([Figure 7](#fig7){ref-type="fig"}E).

Discussion {#sec3}
==========

In this study, we applied single-cell RNA-seq protocols to clusters of cells to determine genome-wide transcriptional activity in developing embryonic lineages. This analysis defined stage-specific gene expression modules of lineage identity and fate specification. Furthermore, our data establish that mouse ESCs and diapaused epiblasts sustain preimplantation epiblast identity despite major environmental or metabolic changes. We found the regulatory network governing naive pluripotency in ESCs to be progressively activated in the embryo and maximally around E4.5. Heterogeneous ICM cells may individually progress to this stage over the preceding 12--18 hr. Indeed, from E3.75 onward, ESCs can be derived from single ICM cells in stringent 2i/LIF culture ([@bib8]).

The gene expression module of the pre- and postimplantation epiblast contains drivers that act to dismantle the naive pluripotency circuitry. Prominent examples include *Fgf4*, an activator of Erk signaling and subsequent differentiation ([@bib34]), and *Tcf7l1* (*Tcf3*), a repressor of naive pluripotency ([@bib46], [@bib88], [@bib94]). Consequently, naive pluripotency factors are abruptly eliminated upon implantation. These data are inconsistent with the proposition that pluripotency is an inherently precarious balance, wherein pluripotency factors act continuously as competing lineage specifiers ([@bib42]). Restriction to preimplantation development precludes these factors from playing a role in lineage specification. We propose that pluripotency is not intrinsically poised for differentiation but progresses through at least three phases: naive, formative, and primed ([@bib29]). Lineage-specific profiling of the E5.5 epiblast is expected to capture the fundamental attributes of the formative phase.

We uncovered parallels in signaling activity between ESC and diapause. Stabilization of β-catenin via GSK3 inhibition is important for maintenance of naive pluripotency in mouse ESCs ([@bib88], [@bib96]). Abrogation of *Tcf7l1* function by β-catenin results in stable expression of the key pluripotency factors *Esrrb*, *Klf2*, and *Nanog* ([@bib46], [@bib88]). This effect of GSK3 inhibition can be partially reproduced by WNT, and together with either LIF stimulation or MAPK/ERK kinase (MEK) inhibition allows continuous propagation of mouse ESCs ([@bib16], [@bib79], [@bib88], [@bib96]). In diapaused epiblasts, we identified high levels of the Jak/Stat downstream targets *Klf4* and *Tfcp2l1* ([@bib9], [@bib47]) and expression of *Lifr* and *Il6st* (*gp130*), reflecting the essential role of LIF signaling in diapause ([@bib56]). We also observed strong *Wnt4* and *Axin2* expression in diapause, potentially indicative of WNT signaling activity. Because *Tcf7l1* is expressed during diapause, WNT signaling may be important for sustaining naive pluripotency in the dormant epiblast. We speculate that pathways evolved to mediate developmental arrest in vivo may facilitate in vitro capture of the naive state ([@bib56], [@bib54]).

In primate embryos, we found the majority of pluripotency-associated genes to be expressed in the ICM. However, absence of KLF2, NR0B1, FBXO15, and BMP4 suggests adaptations in the wider pluripotency network. Similar patterns are observed in human embryos ([@bib7], [@bib92]), lending support for a high degree of conservation of core regulatory interactions in primates. Indeed, the majority of human epiblast-specific factors including KLF17, LEFTY1, and NODAL ([@bib7]) are also expressed in the late marmoset ICM. These data confirm similarities between human and marmoset, and highlight the relevance of tractable nonhuman primate species as a model for early development.

Transcriptional data revealed dissimilar expression of FGF, WNT, and TGF-β/Nodal pathway genes. In human, there are conflicting reports regarding the role of TGF-β/Nodal signaling in the embryo ([@bib7], [@bib86]). We show that NANOG expression in the marmoset ICM does not require FGF, WNT, and TGF-β/Nodal signaling. In particular, we noted an increase in NANOG-positive cells when ERK activation is inhibited by PD03. Robust expression of *Nanog* in the absence of FGF/ERK signaling is reported in a variety of species, including mouse, rat, bovine, and human blastocysts ([@bib33], [@bib57], [@bib64]), and may present a general feature of naive pluripotency in mammals. Recent advances in the generation of naive pluripotent human ESCs ([@bib75], [@bib81]) provide support for this hypothesis.

Suppression of MEK via PD03 blocks PrE formation in rodent embryos ([@bib3], [@bib33], [@bib57], [@bib62], [@bib64], [@bib91]). This effect seems to be attenuated in human ([@bib33], [@bib64]), suggesting involvement of additional mechanisms. We found that WNT inhibition increased NANOG, GATA6, and CDX2 in marmoset embryos, leading to a blurring of lineage boundaries. Cells failing to undergo lineage specification may remain trapped at an earlier developmental stage when NANOG and GATA6 are coexpressed. Interference with ERK signaling reduced the number of PrE cells and broadened expression of CDX2 and NANOG. We propose that lineage specification in primate preimplantation development is regulated by both WNT and FGF/ERK pathways, in contrast to mouse, where FGF/ERK is the primary and sufficient driver ([Figure 7](#fig7){ref-type="fig"}E).

This study provides a comprehensive resource for identifying the factors and pathways that ignite and extinguish naive pluripotency in vivo. Knowledge gained should be valuable for evaluating and optimizing ESC differentiation and reprogramming to pluripotency in vitro. A further application may be to influence lineage decisions in embryo culture in order to facilitate stem cell derivation or even to improve human blastocyst development for assisted conception.

Experimental Procedures {#sec4}
=======================

Mouse Strains and Embryo Collection {#sec4.1}
-----------------------------------

Mice used were intercrosses of *Pdgfra::GFP* ([@bib25]) and strain 129 estrus-checked females. Embryos were collected at the relevant stages from the oviduct or uterus in M2 medium (Sigma). Embryonic diapause was induced by surgical removal of both ovaries on the morning of the third day of pregnancy (E2.5). Diapaused embryos were flushed on the seventh day of pregnancy. Experiments were performed in accordance with EU guidelines for the care and use of laboratory animals, and under authority of UK governmental legislation. Use of animals in this project was approved by the ethical review committee for the University of Cambridge, and relevant Home Office licenses are in place.

Marmoset Colony Maintenance and Embryo Collection {#sec4.2}
-------------------------------------------------

Primate embryos were obtained from the German Primate Center, Göttingen (Deutsches Primatenzentrum; DPZ) and the Central Institute for Experimental Animals, Kanagawa, Japan (CIEA). Marmoset blastocysts were retrieved by nonsurgical uterine flush according to established methods using recently developed devices ([@bib74], [@bib82]). Because the time of conception must be determined retrospectively and with an accuracy of ±24 hr, we applied additional criteria to embryo staging such as blastocoel formation and diameter ([Figure 5](#fig5){ref-type="fig"}A). Staging of female reproductive cycles and protocols for embryo retrieval have been described ([@bib26]). Animals were obtained from self-sustaining colonies and housed according to standard husbandry guidelines. Protocols for the use of animals and institutional regulations for the care and experimental use of marmosets were strictly followed. Experiments at the DPZ were conducted under license number AZ 33.42502--066/06. Experiments using marmosets at the CIEA were approved by the animal research committee (CIEA 11028) and performed in compliance with guidelines set forth by the Science Council of Japan.

Isolation of Single-Cell Suspensions {#sec4.3}
------------------------------------

Mouse (E3.25--E4.5) and marmoset blastocysts were subjected to immunosurgery as previously described ([@bib55], [@bib71]). ICMs were subsequently dissociated from residual trophectoderm with a narrowly fitting Pasteur pipette. For postimplantation mouse embryos, the epiblast was isolated by manual dissection. Dissociation of morulae, ICM, and postimplantation epiblast was carried out in a mixture of trypsin and chick serum (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Cells were dissociated by repetitive pipetting using blunted microcapillaries.

Embryonic Stem Cell Culture {#sec4.4}
---------------------------

E14TG2a cells derived from mouse strain 129/Ola ([@bib28]) were used as a reference ESC line and cultured in 2i/LIF conditions ([@bib96]). N2B27 (1:1 DMEM/F-12 and Neurobasal media, N2 \[in-house\] and B27 \[GIBCO\] additives, 2 mM L-glutamine, and 100 μM β-mercaptoethanol) was supplemented with 1 μM PD0325901, 3 μM CHIR99021, and 10 ng/ml LIF (in-house), and cells were maintained in gelatin-coated (0.1%) culture vessels. Cells were dissociated by conventional methods, and 20 cells per sample were manually selected with a blunt microcapillary.

Transcriptome Analysis {#sec4.5}
----------------------

Library construction was carried out using whole-transcriptome preamplification ([@bib76], [@bib78]) followed by sonication of cDNA and preparation of Illumina-compatible sequencing constructs (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Sequencing reads were processed to remove preamplification adapters and were aligned with GSNAP ([@bib89]). Global analyses were based on variance-stabilized counts computed with the Bioconductor package DESeq ([@bib2]). Differential expression analysis was performed in DESeq. Gene clusters were identified by hierarchical clustering on scaled FPKMs. The GOstats R package ([@bib18]) was used for GO category and KEGG pathway enrichment analysis. High-level comparative analysis of KEGG pathways was based on the mean expression of constituent genes. For analysis of individual pathways, expression values were mapped onto pathway nodes using PathVisio ([@bib36]). PluriNet82 was created by intersecting PluriNetWork ([@bib72]) with dynamically expressed genes. Preferential activity at a given embryonic stage was defined as positive-scaled log-normalized expression for a network node; a network edge was required to have active source and target nodes. Cytoscape ([@bib70]) was used for network visualization.
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![Transcriptome Profiling of Mouse Embryonic Lineages\
(A) Overview of the developmental sequence analyzed.\
(B) Percentage of detected genes in RNA-seq data from single cells (white), small numbers of cells (blue), and conventional bulk RNA (black) on comparable cell types ([@bib90], [@bib92], [@bib45]).\
(C) Distribution of nonzero expression values in log~2~ FPKM (fragments per kilobase of exon per million fragments mapped) for RNA-seq data from single cells (white), small numbers of cells (blue), and conventional bulk RNA (black).\
(D) Diffusion map of embryonic samples from morula to postimplantation epiblast; DC, diffusion coefficient.\
(E) Marker expression delineates the divergence of epiblast and PrE lineages. Genes specific to PrE and the preimplantation epiblast are marked in green and blue, respectively; shared genes are depicted in orange. Track width is scaled to relative expression normalized to the mean across all stages displayed.](gr1){#fig1}

![Expression Modules Identified in Early Mouse Development and the Preimplantation-to-Postimplantation Epiblast Transition\
(A) Expression of dynamically expressed genes. Modules were derived by hierarchical clustering of scaled expression values. Selected transcription factors, signaling pathway components, and epigenetic regulators are shown with pluripotency-associated genes in bold.\
(B) PluriNet82 at the transition from pre- to postimplantation stages. Label and node sizes reflect interaction number. Colors represent expression in FPKM for preimplantation (E4.5; left) and postimplantation epiblasts (E5.5; right). Arrows indicate positive interactions; T bars indicate inhibitions.\
(C) Genes characteristic of preimplantation (green) and early postimplantation development (red). Track width is scaled to relative expression normalized to the mean across all stages displayed.\
(D) Epigenetic modifiers expressed predominantly at preimplantation (green) or early postimplantation (red) stages.\
(E) Simplified representation of the KEGG "tight junction" pathway, with nodes colored according to expression in the preimplantation (left) and postimplantation epiblast (right).](gr2){#fig2}

![ESCs Retain Expression Modules Defining the Preimplantation Epiblast\
(A) Diffusion map from morula to postimplantation epiblast and ESC cultured in 2i/LIF, based on dynamically expressed genes.\
(B) Genes differentially expressed (p \< 0.05) between ESCs and embryonic samples.\
(C) Most significantly enriched GO and KEGG pathways based on up- and downregulated genes in ESC versus preimplantation epiblast.\
(D) Changes in expression of PluriNet82 genes in the embryonic lineage. A node is displayed if the corresponding gene is predominantly active at that developmental stage, defined as positive log-transformed expression relative to the mean across all stages. An edge is displayed if both source and target nodes are active.\
(E) Minimal set of transcription factors operative in mouse ESCs ([@bib16]). Colors represent gene expression in FPKM. Expression levels are depicted for morula, early ICM, and pre- and postimplantation epiblasts clockwise from the top left.](gr3){#fig3}

![Relationship between Diapaused Epiblast, Normal Embryonic Development, and ESC\
(A) Diffusion map of developmental stages from morula to postimplantation epiblast, ESC, and diapaused epiblast.\
(B) Expression scores for selected signaling pathways, scaled to the mean across the three cell types, calculated by summing FPKM values of individual components followed by normalization for pathway size.\
(C) Selected components of WNT and JAK/STAT signaling pathways for the samples indicated.\
(D) Ternary plot of the most divergent transcriptional and epigenetic regulators between preimplantation epiblast, ESC, and diapaused epiblast. FPKM values are scaled to the mean across the three cell types and are log transformed.\
(E) Differentially expressed genes in FPKM between preimplantation epiblast, diapaused epiblast, and ESC, as indicated.\
(F) Diffusion map based on dynamically expressed genes from morula to postimplantation epiblast, ESC, and diapaused epiblast.](gr4){#fig4}

![Pluripotency Factors Are Conserved, whereas Signaling Receptors Diverge, in Mouse and Marmoset ICM\
(A) Staging criteria for isolation of early, mid, and late marmoset ICM and images of the blastocysts analyzed.\
(B) Diffusion map of mouse and marmoset embryonic samples.\
(C) Pluripotency gene expression for mouse and marmoset embryonic samples. Error bars represent SD.\
(D and E) Confocal z projections of whole-mount marmoset early-mid blastocyst immunofluorescence stainings for the markers indicated.\
(F) PrE-associated gene expression for mouse and marmoset embryonic samples. Error bars represent SD.\
(G--J) Immunofluorescence stainings of early, mid (H), and late marmoset blastocyst.\
(K) z-x cross-section of marmoset blastocyst stained for the markers indicated.](gr5){#fig5}

![FGF and WNT Inhibition Disrupt Lineage Segregation in the Marmoset Blastocyst\
(A--C) Expression of selected components of the TGF-β/NODAL, FGF, and WNT signaling pathways.\
(D) Confocal z projections of inhibitor-treated marmoset late blastocysts stained for NANOG, CDX2, GATA6, and DAPI.\
(E) Fluorescence signal from cells labeled for lineage markers in mouse and marmoset embryos. Morulae were cultured under identical conditions to the late blastocyst stage in the presence of A8301 (3 μM), PD0325901 (3 μΜ), IWP2 (3 μΜ), or DMSO (control) for 3 and 4 days in mouse and marmoset, respectively.\
(F--H) Quantification of (F) NANOG-only, (G) NANOG-high, and (H) GATA6-only cells. Plotted are the first and second quartiles of data points (boxed) with error bars at minimum and maximum values. Outliers are indicated with a cross. NANOG-high cells displayed at least 1.5× average NANOG fluorescence intensity. p values were computed by one-way ANOVA with Tukey HSD (honest significant difference) testing.](gr6){#fig6}

![Dual FGF and WNT Inhibition Increases NANOG Levels and Blocks PrE Formation\
(A) Confocal z projections of inhibitor-treated marmoset late blastocysts stained for NANOG, CDX2, GATA6, and DAPI.\
(B--D) Fluorescence quantification of (B) NANOG-only, (C) NANOG-high, and (D) GATA6-only cells. Outliers are indicated with a cross. NANOG-high cells displayed at least 1.5× average NANOG fluorescence intensity. p values were computed by one-way ANOVA with Tukey HSD testing.\
(E) Model of pathways driving lineage specification in mouse and marmoset ICM.](gr7){#fig7}
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